These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 24842074)
1. Genetic variants in the glutathione S-transferase genes and survival in colorectal cancer patients after chemotherapy and differences according to treatment with oxaliplatin. Kap EJ; Richter S; Rudolph A; Jansen L; Ulrich A; Hoffmeister M; Ulrich CM; Brenner H; Chang-Claude J Pharmacogenet Genomics; 2014 Jul; 24(7):340-7. PubMed ID: 24842074 [TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms in GST genes and survival of colorectal cancer patients treated with chemotherapy. Funke S; Timofeeva M; Risch A; Hoffmeister M; Stegmaier C; Seiler CM; Brenner H; Chang-Claude J Pharmacogenomics; 2010 Jan; 11(1):33-41. PubMed ID: 20017670 [TBL] [Abstract][Full Text] [Related]
3. Glutathione S-transferase P1 polymorphism (Ile105Val) predicts cumulative neuropathy in patients receiving oxaliplatin-based chemotherapy. Lecomte T; Landi B; Beaune P; Laurent-Puig P; Loriot MA Clin Cancer Res; 2006 May; 12(10):3050-6. PubMed ID: 16707601 [TBL] [Abstract][Full Text] [Related]
4. Association between glutathione S-transferase P1, T1, and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer. Stoehlmacher J; Park DJ; Zhang W; Groshen S; Tsao-Wei DD; Yu MC; Lenz HJ J Natl Cancer Inst; 2002 Jun; 94(12):936-42. PubMed ID: 12072547 [TBL] [Abstract][Full Text] [Related]
5. Glutathione S-transferase M1, T1, and P1 polymorphisms and survival among lung cancer patients. Sweeney C; Nazar-Stewart V; Stapleton PL; Eaton DL; Vaughan TL Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):527-33. PubMed ID: 12814998 [TBL] [Abstract][Full Text] [Related]
7. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility. Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357 [TBL] [Abstract][Full Text] [Related]
8. DNA repair genes XPC, XPG polymorphisms: relation to the risk of colorectal carcinoma and therapeutic outcome with Oxaliplatin-based adjuvant chemotherapy. Liu D; Wu HZ; Zhang YN; Kang H; Sun MJ; Wang EH; Yang XL; Lian MQ; Yu ZJ; Zhao L; Olopade OI; Wei MJ Mol Carcinog; 2012 Oct; 51 Suppl 1():E83-93. PubMed ID: 22213216 [TBL] [Abstract][Full Text] [Related]
9. Glutathione-S-transferase pi (GSTP1) codon 105 polymorphism is not associated with oxaliplatin efficacy or toxicity in advanced colorectal cancer patients. Kweekel DM; Gelderblom H; Antonini NF; Van der Straaten T; Nortier JW; Punt CJ; Guchelaar HJ Eur J Cancer; 2009 Mar; 45(4):572-8. PubMed ID: 19084393 [TBL] [Abstract][Full Text] [Related]
10. XRCC1 and GSTP1 polymorphisms and prognosis of oxaliplatin-based chemotherapy in colorectal cancer: a meta-analysis. Ye F; Liu Z; Tan A; Liao M; Mo Z; Yang X Cancer Chemother Pharmacol; 2013 Mar; 71(3):733-40. PubMed ID: 23299794 [TBL] [Abstract][Full Text] [Related]
11. Glutathione S-transferases mu 1, theta 1, pi 1, alpha 1 and mu 3 genetic polymorphisms and the risk of colorectal and gastric cancers in humans. Martínez C; Martín F; Fernández JM; García-Martín E; Sastre J; Díaz-Rubio M; Agúndez JA; Ladero JM Pharmacogenomics; 2006 Jul; 7(5):711-8. PubMed ID: 16886896 [TBL] [Abstract][Full Text] [Related]
12. Glutathione S-transferase M1, T1 and P1 polymorphisms: susceptibility and outcome in lung cancer patients. Sreeja L; Syamala V; Hariharan S; Syamala VS; Raveendran PB; Sivanandan CD; Madhavan J; Ankathil R J Exp Ther Oncol; 2008; 7(1):73-85. PubMed ID: 18472644 [TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in p53, GSTP1 and XRCC1 predict relapse and survival of gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy. Huang ZH; Hua D; Du X Cancer Chemother Pharmacol; 2009 Oct; 64(5):1001-7. PubMed ID: 19247656 [TBL] [Abstract][Full Text] [Related]
14. Glutathione S-transferase polymorphisms and survival in African-American and white colorectal cancer patients. Jones BA; Christensen AR; Wise JP; Yu H Cancer Epidemiol; 2009 Oct; 33(3-4):249-56. PubMed ID: 19748847 [TBL] [Abstract][Full Text] [Related]
15. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study. Matic M; Pekmezovic T; Djukic T; Mimic-Oka J; Dragicevic D; Krivic B; Suvakov S; Savic-Radojevic A; Pljesa-Ercegovac M; Tulic C; Coric V; Simic T Urol Oncol; 2013 Oct; 31(7):1184-92. PubMed ID: 24075358 [TBL] [Abstract][Full Text] [Related]
16. Clinical implications of glutathione S-transferase genotyping in patients with diffuse large B-cell lymphoma. Atanaskovic L; Cikota-Aleksic B; Tarabar O; Trimcev J; Zivanovic-Ivic A; Marjanovic S; Magic Z J BUON; 2016; 21(6):1459-1465. PubMed ID: 28039708 [TBL] [Abstract][Full Text] [Related]
17. Glutathione S-transferase T1 polymorphisms are associated with outcome in colorectal cancer. Rajagopal R; Deakin M; Fawole AS; Elder JB; Elder J; Smith V; Strange RC; Fryer AA Carcinogenesis; 2005 Dec; 26(12):2157-63. PubMed ID: 16051638 [TBL] [Abstract][Full Text] [Related]
18. The role of glutathione-S-transferase polymorphisms in ovarian cancer survival. Nagle CM; Chenevix-Trench G; Spurdle AB; Webb PM Eur J Cancer; 2007 Jan; 43(2):283-90. PubMed ID: 17084623 [TBL] [Abstract][Full Text] [Related]
19. Glutathione S-transferase M1 and T1 polymorphisms: susceptibility and outcomes in muscle invasive bladder cancer patients. Kang HW; Song PH; Ha YS; Kim WT; Kim YJ; Yun SJ; Lee SC; Choi YH; Moon SK; Kim WJ Eur J Cancer; 2013 Sep; 49(14):3010-9. PubMed ID: 23810248 [TBL] [Abstract][Full Text] [Related]
20. The role of the glutathione S-transferase genes GSTT1, GSTM1, and GSTP1 in acetaminophen-poisoned patients. Buchard A; Eefsen M; Semb S; Andersen SE; Morling N; Bendtsen F; Larsen FS; Dalhoff K Clin Toxicol (Phila); 2012 Jan; 50(1):27-33. PubMed ID: 22175791 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]